As on Thursday, Phio Pharmaceuticals Corp (NASDAQ: PHIO) started slowly as it slid -9.49% to $1.43, before settling in for the price of $1.58 at the close. Taking a more long-term approach, PHIO posted a 52-week range of $0.97-$9.79.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 66.30%. Meanwhile, its Annual Earning per share during the time was 66.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 82.49%. This publicly-traded company’s shares outstanding now amounts to $4.80 million, simultaneously with a float of $4.48 million. The organization now has a market capitalization sitting at $8.19 million. At the time of writing, stock’s 50-day Moving Average stood at $2.1052, while the 200-day Moving Average is $2.0077.
Phio Pharmaceuticals Corp (PHIO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Phio Pharmaceuticals Corp’s current insider ownership accounts for 26.06%, in contrast to 3.59% institutional ownership. According to the most recent insider trade that took place on Jun 10 ’25, this organization’s Chairman, Pres & CEO bought 2,000 shares at the rate of 2.42, making the entire transaction reach 4,840 in total value, affecting insider ownership by 27,149. Preceding that transaction, on Jun 10 ’25, Company’s Director bought 2,500 for 2.42, making the whole transaction’s value amount to 6,050. This particular insider is now the holder of 15,666 in total.
Phio Pharmaceuticals Corp (PHIO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year. Phio Pharmaceuticals Corp’s EPS increase for this current 12-month fiscal period is 82.49% and is forecasted to reach -0.98 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 64.39% through the next 5 years, which can be compared against the 66.30% growth it accomplished over the previous five years trading on the market.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Trading Performance Indicators
Let’s observe the current performance indicators for Phio Pharmaceuticals Corp (PHIO). It’s Quick Ratio in the last reported quarter now stands at 9.36.
In the same vein, PHIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.34, a figure that is expected to reach -0.45 in the next quarter, and analysts are predicting that it will be -0.98 at the market close of one year from today.
Technical Analysis of Phio Pharmaceuticals Corp (PHIO)
Through scrutinizing the latest numbers posted by the [Phio Pharmaceuticals Corp, PHIO], it can be observed that its last 5-days Average volume of 0.99 million was lower the volume of 3.76 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 6.69% While, its Average True Range was 20.94.
Raw Stochastic average of Phio Pharmaceuticals Corp (PHIO) in the period of the previous 100 days is set at 2.82%, which indicates a major rise in contrast to 2.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.3050 that was higher than 0.1649 volatility it exhibited in the past 100-days period.
